ALK33-101: A Study of RDC-0313 (ALKS 33) in Adults With Binge Eating Disorder

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2010
The purpose of this study is to evaluate the safety of daily doses of RDC-0313 (ALKS 33) compared with placebo in adults with binge-eating disorder (BED). An additional objective is to explore the efficacy of RDC-0313 treatment in comparison with placebo in adults with binge-eating disorder.
Epistemonikos ID: bca360827b64de2484508192ea6b436bc627fdaf
First added on: May 05, 2024